We are excited to announce our collaboration with WBR Insights in producing its first annual sustainability report. SkyCell played a pivotal role by crafting insightful survey questions, providing commentary, and presenting tangible solutions for achieving sustainability targets in the pharmaceutical industry.
We are thrilled to announce that SkyCell and Delta Cargo have embarked on a strategic partnership. This collaboration marks a significant advancement in secure and efficient pharmaceutical shipping, with Delta Cargo integrating SkyCell’s state-of-the-art containers to enhance their service offerings.
In a significant development, SkyCell has secured a $57 million funding round in partnership with Catalyst, M&G Investments' $6 billion purpose-led private assets strategy. This strategic investment is poised to accelerate SkyCell’s global expansion and bolster its mission to establish safer, more sustainable, and highly efficient pharmaceutical supply chains.
Discover how SkyCell sustainably shipped around 8.8 million vaccines to the Brazilian Government, allowing patients to receive their essential medicine in the quality required, all while reducing the impact that shipments like these normally impose on our planet.
In recent weeks many parts of Europe, Asia, and the US have endured searing heat waves as global temperatures reached record-breaking highs. Tarmac temperatures are reported to have reached 60°C at certain airports. As global infrastructure are reaching their limits, it’s the packaging that needs to step up at this crucial moment.
SkyCell is proud to announce its latest partnership with Marken, the clinical trials logistics subsidiary of UPS Healthcare, that specializes in providing global supply chain solutions from clinical to commercial. The collaboration will provide Marken with SkyCell containers to ship critical and temperature-sensitive drugs worldwide.
SkyCell is pleased to share with you our third annual Sustainability Report. We believe it is an important part of our mission to detail the progress made in achieving our sustainability targets and share these with all our stakeholders.
SkyCell is pleased to welcome Lazard Asset Management as a new shareholder, following their recent acquisition of a minority stake in our company.
SkyCell and Etihad Cargo successfully completed a shipment of temperature-sensitive vaccines in two 1500C containers between Amsterdam and Manila, via Abu Dhabi.
During the past two decades, the value of pharmaceutical goods traded globally has grown sixfold, from $113 billion in 2000 to $629 billion in 2019¹. As a result of this growth, supply chains have become increasingly global and complex, with current regulations being too focused on managing a ‘black box’ without visibility on the status of the shipment.
The 1500X - SkyCell’s next generation of hybrid container - continues to steer the industry in reaching new levels of performance in sustainability and efficiency. The container raises the bar for protecting pharma shipments at +2°C to +8°C or +15°C to +25°C and ensures protection for an unbroken cold chain.
No spoilage, no excursion and on time: hybrid solution delivers on challenging multinational shipment
With disruptions to pharma shipments possible at any number of points along the supply chain, robust solutions are required if substantial wastage of medicines is not to occur. For temperature-sensitive goods, this concern is even greater given additional logistical challenges. That’s where hybrid solutions come into consideration.
The next generation of hybrid containers has arrived - the 1500X. Discover more on best in class performance, door-to-door security for an unbroken cold chain and greater optimization of efficiency features.
As China went into lockdown, SkyCell successfully delivered life-saving vaccines door-to-door from Europe to Beijing
Conditions on the ground for logistics businesses currently operating in China are challenging. Discover how SkyCell was well disposed to meet this challenge head on with our hybrid 2500C containers and the SECURE real-time monitoring platform.
SkyCell updates its container lineup with the 1500X Hybrid container with 270 hours independent runtime for temperature-sensitive pharma product transportation
SkyCell has launched the new 1500X container, the next generation in its hybrid container portfolio. Discover more on how it ensures protection for an unbroken cold chain.
SkyCell has partnered with Japan Airlines Cargo, to meet Japan's growing needs for vaccine and pharmaceutical transportation. Read more on this exciting new partnership that will strengthen SkyCell's presence in Japan.
Our CEO and Co-Founder, Richard Ettl, spoke to Emma Betuel from TechCrunch about our successful $35M in Series C funding, as well as many issues related to the biopharma industry itself. Read more about the coverage here and access the TechCrunch article.
This latest round of investment funding consolidates SkyCell’s position in strategically important Middle and Far East regions, setting the stage for a new phase of growth capitalizing on surging global demand for safe, secure, and sustainable pharma cold-chain solutions.
SkyCell has opened a new service center in Puerto Rico to facilitate shipments to local pharma clients and patients on the island and throughout the region. See how SkyCell could help you with future shipments to Puerto Rico and beyond.
SkyCell has partnered with All Nippon Airways (ANA), Japan's largest airline. This partnership will not only strengthen our support for pharmaceutical customers shipping in and out of Japan, but will also benefit ANA in reaching their own sustainability goals.
For the fourth year in a row, SkyCell has upheld its high-performance title with an audit proving less than 0.1% temperature excursions occur end-to-end of our shipments. Take a look to learn more.
SkyCell SECURE is the start of our bold new chapter. A SaaS platform, it is ready to optimize pharma supply chains and to take the industry forwards. Explore its early development and what it means for the industry at large.
SkyCell has partnered with Etihad Cargo to bring customers a wide range of solutions to transport their temperature-controlled pharmaceuticals in a safe, secure, and sustainable way.
SkyCell has joined forces with LATAM Cargo Group to expand their pharma services and protection by utilizing our hybrid containers across their South American network. This will add further shielding for shipments heading to Brazil, Argentina, Chile and more.
SkyCell has signed an agreement with LOT Airlines that will extend LOT Cargo's capabilities in the transport of medicines and pharmaceutical products using our innovative hybrid containers.
SkyCell and DB Schenker have announced a new partnership that will transform its logistics services to transport life-saving vaccines and medicines to remote areas around the world.
SkyCell recently collaborated with our partner, Alitalia, to ship 3 million meningitis vaccine doses from Rome to Belo Horizonte in order to support Brazil’s National Immunization Program for children and adolescents.
SkyCell has formed a new partnership with Virgin Atlantic that brings together the commitment of both companies to provide innovative solutions and use sustainable resources to ensure the safe and secure shipment of valuable pharma products and vital vaccines.
SkyCell has developed the new 1500F, the fourth temperature range which completes the product suite from deep frozen to controlled room temperature. The 1500F, which maintains a steady temperature of -15°C to -25°C for more than 120 hours.
SkyCell and Korean Air Cargo have signed an agreement to lease SkyCell's hybrid containers. The partnership follows SkyCell’s recent launch of a service center in Seoul and the appointment of a Business Development Director for Korea.
SkyCell’s new deep-frozen solution is capable of maintaining a steady temperature of minus 60° Celsius to minus 80° Celsius, while reducing the amount of dry-ice by more than half. Explore our latest product innovation.
SkyCell has become part of the establishment of the Hope Consortium – a neutral platform that offers a scalable solution to reach emerging markets in best-in-class quality. The consortium will facilitate the distribution of over 1.8 billion Covid-19 vaccines by end of 2021.
SkyCell and Air France KLM Martinair Cargo have signed a partnership agreement to expand access to SkyCell's hybrid containers in supply chains, enabling further safety and sustainability solutions for pharmaceutical shipments. The new deal is part of a shift towards the adoption of enhanced technological solutions to meet both the demands of pandemic logistics and requirements of environmental agreements.
SkyCell has opened new Service Centers in Korea, Italy and the USA. Virtual training and digitalization projects have enabled expansion to continue in spite of Covid-19 lockdowns. This expansion responds to increased global demand for temperature-controlled, IoT- tracked containers as pharma shippers begin answering to greater need for pharmaceuticals and increased regulatory requirements to protect crucial supply chains.
SkyCell and Unitrans International Corporation (an AIT Worldwide Logistics Company) have partnered up to provide increased access to SkyCell’s hybrid containers for the transport of life-saving pharmaceuticals around the world.
Under the new circumstances of Covid-19, audited data from end-to-end of the supply chain is the most reliable mirror of the truth. For the third year in a row, SkyCell has upheld its high-performance title with an audit* proving <0.1% temperature excursions occur end-to-end of our shipments.
Qatar Airways Cargo and SkyCell have signed an agreement to lease SkyCell hybrid containers. The agreement ensures pharma shippers have increased access to the self-charging, temperature-controlled container to boost the safety and sustainability of their shipments.
Governments around the world are imposing fees upon those delivering goods unsustainably and introducing systems that advocate for sustainable packaging, meaning savings with SkyCell’s hybrid pharmaceutical containers are set to rise.
SkyCell’s CEO and Co-Founder, Richard Ettl, sat down with Monocle 24’s Daniel Bach to talk about SkyCell’s growth over the past decade, from the earliest days of an idea to becoming a global leader in the field, and now working with 15 of the top 20 pharmaceutical companies worldwide.
Here's why data insights are essential to guaranteeing the safe and sustainable distribution of a life-saving Covid-19 vaccine.
We are writing the next chapter in the SkyCell story with the unveiling of your new strapline. We have decided to bring into the spotlight what is important to our clients, partners, investors and to us at SkyCell: our values. Learn why sustainability should matter to you.
The importance of temperature control in pharma distribution has not gone unnoticed in the investment community. SkyCell closes an oversubscribed financing round of 62M USD to expand its global footprint and container fleet.
SkyCell is proud to let you know that even during the restrictions put in place due to COVID-19, 100% of our deliveries of the last four weeks were on time. We are aware that even minor disruptions can cause delays in delivering life-saving drugs to patients and potential financial losses. We would like to highlight the measures SkyCell has taken to maintain a high level of performance during the COVID-19 pandemic, ensuring your supply chains' resilience.
Learn more about SkyCell's approach of tackling supply chain emissions and building a sustainable pharma supply chain.
Collecting and reporting data in near real-time cuts costs and reduces risk. Learn more about our IoT infrastructure, software developments and big data systems.
Quality is everything to us, which is why each SkyCell smart container has a digital identity that is used for tracking it through blockchain technology, wherever it is located in the world. This is made possible by equipping it with public and private keys generated by Securosys Hardware Security Modules.
Two years of partnership with zero temperature excursions. For its outstanding performance in pharma transport, Emirates SkyCargo was honored with the first SkyCell Quality Award.
SkyCell and United Cargo have announced a close partnership which makes United Cargo the first U.S. carrier to lease and transport the innovative temperature-sensitive containers manufactured by SkyCell.
AirBridgeCargo Airlines (ABC) and SkyCell have sealed a close partnership for the lease of all types of SkyCell’s temperature-controlled containers.
SkyCell and Singapore Airlines (SIA) have sealed a partnership for the lease of SkyCell containers to serve the surging demand in Singapore and the Asia Pacific Region. Learn what kind of benefits the collaboration brings for SkyCell clients.
Being the safest pharma container is not enough. SkyCell expands its SkyCellent services with a new additional offering.
SkyCell and Air France KLM Martinair Cargo have announced a global cooperation to work more closely together on existing and future pharmaceutical logistics business.